Christmas & New Year Discount Image

Global Assisted Reproductive Technology (ART) Market by Technology (In Vitro-fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Replacement (FER), and others), By End-Users (Hospital, and Fertility Clinics), Regional Forecasts 2021-2027

  • Category: Healthcare
  • Published Date: Oct 2021
  • Publisher: Bizwit Research
  • Pages: 200

Global Assisted Reproductive Technology Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2021-2027. Assisted Reproductive Technology (ART) is used to treat infertility. In vitro fertilization (IVF) is the effective and most common form of ART. Whereas, multiple pregnancy related issues is the most common problem associated with ART. The market is driven by the key factors such as Rise in Number of Single Women and Same-sex Couples and increasing number of Infertility Cases. According to the World Health Organization (WHO), 186 million people and 48 million couples were diagnosed with infertility by 2020. According to the Centers for Disease Control and Prevention (CDC), around 6 percent to 12 percent of PCOS-affected women in the United States also have infertility issues. As a result, the infertility rate rises with the rise in prevalence of PCOS, fueling the demand for assisted reproductive technologies. One of the contributing factors to market growth is technological advancements. For instance, VitriCell SA announced the achievement of a USD 1.2 million investment in January 2018. These funds are intended to help the company to launch aseptic vitrification-based goods (new cell cryopreservation technique). In the next years, this is likely to have a beneficial influence on the ART market. However, Changing Government Regulations, may impede market growth over the forecast period of 2021-2027.

Geographically, Europe is the leading region and holding the major share of market due to the increase in utilization of novel technology equipment services, high disposable income and rise in incidence of infertility cases. However, Asia pacific is the fastest growing region factors are rise in awareness about surrogacy and increase in demand for assisted reproductive technology.


Major market player included in this report are:

FUJIFILM Irvine Scientific, Inc.
Bloom IVF Centre
Nidacon International AB
Hamilton Thorne Inc.
OvaScience Inc.
CooperSurgical Inc
Laboratoire CCD
Ferring B.V.
Vitrolife
Microm Ltd



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
In Vitro-fertilization (IVF)
Artificial Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By End user:
Hospital
Fertility Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Assisted Reproductive Technology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Assisted Reproductive Technology Market, by region, 2019-2027 (USD Billion)
1.2.2. Assisted Reproductive Technology Market, by Technology, 2019-2027 (USD Billion)
1.2.3. Assisted Reproductive Technology Market, by End user, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Assisted Reproductive Technology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Assisted Reproductive Technology Market Dynamics
3.1. Assisted Reproductive Technology Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rise in Number of Single Women and Same-sex Couples
3.1.1.2. Increasing Number of Infertility Cases
3.1.2. Market Restraint
3.1.2.1. Changing Government Regulations
3.1.2.2. High Cost and Socio-ethical Issues
3.1.3. Market Opportunities
3.1.3.1. Growing opportunities in emerging market and rise in fertility tourism
Chapter 4. Global Assisted Reproductive Technology Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Assisted Reproductive Technology Market, by Technology
5.1. Market Snapshot
5.2. Global Assisted Reproductive Technology Market by Technology, Performance - Potential Analysis
5.3. Global Assisted Reproductive Technology Market Estimates & Forecasts by Technology 2018-2027 (USD Billion)
5.4. Assisted Reproductive Technology Market, Sub Segment Analysis
5.4.1. In Vitro-fertilization (IVF)
5.4.2. Artificial Insemination (AI-IUI)
5.4.3. Frozen Embryo Replacement (FER)
5.4.4. Others
Chapter 6. Global Assisted Reproductive Technology Market, by End user
6.1. Market Snapshot
6.2. Global Assisted Reproductive Technology Market by End user, Performance - Potential Analysis
6.3. Global Assisted Reproductive Technology Market Estimates & Forecasts by End user 2018-2027 (USD Billion)
6.4. Assisted Reproductive Technology Market, Sub Segment Analysis
6.4.1. Hospital
6.4.2. Fertility Clinics
Chapter 7. Global Assisted Reproductive Technology Market, Regional Analysis
7.1. Assisted Reproductive Technology Market, Regional Market Snapshot
7.2. North America Assisted Reproductive Technology Market
7.2.1. U.S. Assisted Reproductive Technology Market
7.2.1.1. Technology breakdown estimates & forecasts, 2018-2027
7.2.1.2. End User breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Assisted Reproductive Technology Market
7.3. Europe Assisted Reproductive Technology Market Snapshot
7.3.1. U.K. Assisted Reproductive Technology Market
7.3.2. Germany Assisted Reproductive Technology Market
7.3.3. France Assisted Reproductive Technology Market
7.3.4. Spain Assisted Reproductive Technology Market
7.3.5. Italy Assisted Reproductive Technology Market
7.3.6. Rest of Europe Assisted Reproductive Technology Market
7.4. Asia-Pacific Assisted Reproductive Technology Market Snapshot
7.4.1. China Assisted Reproductive Technology Market
7.4.2. India Assisted Reproductive Technology Market
7.4.3. Japan Assisted Reproductive Technology Market
7.4.4. Australia Assisted Reproductive Technology Market
7.4.5. South Korea Assisted Reproductive Technology Market
7.4.6. Rest of Asia Pacific Assisted Reproductive Technology Market
7.5. Latin America Assisted Reproductive Technology Market Snapshot
7.5.1. Brazil Assisted Reproductive Technology Market
7.5.2. Mexico Assisted Reproductive Technology Market
7.6. Rest of The World Assisted Reproductive Technology Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. FUJIFILM Irvine Scientific, Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bloom IVF Centre
8.2.3. Nidacon International AB
8.2.4. Hamilton Thorne Inc.
8.2.5. OvaScience Inc.
8.2.6. CooperSurgical Inc
8.2.7. Laboratoire CCD
8.2.8. Ferring B.V.
8.2.9. Vitrolife
8.2.10. Microm Ltd
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

no record found